Nuveen Asset Management
TLIS

Nuveen Asset Management’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Nuveen Asset Management’s Portfolio TLIS Stock Details TLIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
2022
Q1 		$82K Buy
2021
Q4 		$186K Sell
2021
Q3 		$392K Buy
2021
Q2 		$442K Buy
2021
Q1 		$275K Buy